Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin

NCT02256241 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT02256241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02256241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin
Lead sponsor
Rambam Health Care Campus
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2014
Completion date
July 31, 2019
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

group 1: trauma operation for otherwise healthy patients, group 2: primary tumors of mesenchymal origin